PitchSend

Investor Presentaiton

13 Summary Outstanding 2022 performance with broad-based strength across the portfolio Differentiated positions in highly attractive areas of Biotechnology, Life Sciences and Diagnostics Meaningful opportunities for Danaher and Veralto to generate sustainable long-term shareholder value, driven by DBS DANAHER

View entire presentation